Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Akari Therapeutics NASDAQ AKTX
$1.19 0.0000 0.0000%
Today share price
UK
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 15 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

11.99B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
11.98B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.24
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
10.12B
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-62.02 %
Upcoming events Akari Therapeutics All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Akari Therapeutics

Stock analysis Akari Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-670.41 34.97
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
6,698.30 13.28
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-651.48 17.35
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.72 0.36
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-643.26 9.48

Price change Akari Therapeutics per year

1.42$ 4.21$
Min Max

Summary analysis Akari Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Akari Therapeutics

Revenue and net income Akari Therapeutics

All parameters
Stock news Akari Therapeutics All news
5 March в 17:05

Akari Therapeutics Signs Merger-of-Equals with Peak Bio

19 July 2023 в 15:20

Akari Therapeutics Names Wendy DiCicco Interim Finance Chief

19 July 2023 в 15:20

Akari Therapeutics Names Wendy DiCicco Interim Finance Chief

6 July 2023 в 15:55

Akari Therapeutics Shares Rise 22% After Nomacopan's Positive Orphan Drug Opinion in Europe

6 July 2023 в 15:50

Akari Therapeutics Shares Rise 22% After Nomacopan's Positive Orphan Drug Opinion in Europe

31 March 2023 в 01:11

ADRs End Higher, ABB and Akari Therapeutics Trade Actively

31 March 2023 в 01:06

ADRs End Higher, ABB and Akari Therapeutics Trade Actively

11 November 2022 в 02:00

ADRs End Mostly Higher, Aegon and Akari Therapeutics Trade Actively

11 November 2022 в 01:55

ADRs End Mostly Higher, Aegon and Akari Therapeutics Trade Actively

1 November 2022 в 15:30

Akari Therapeutics started at buy with $4 stock price target at Alliance Global

13 September 2022 в 01:15

ADRs End Higher, Akari Therapeutics and ArcelorMittal Trade Actively

13 September 2022 в 01:15

ADRs End Higher, Akari Therapeutics and ArcelorMittal Trade Actively

2 September 2022 в 00:35

ADRs End Lower; Akari Therapeutics, Alibaba Trade Actively

2 September 2022 в 00:35

ADRs End Lower; Akari Therapeutics, Alibaba Trade Actively

2 August 2022 в 00:36

ADRs End Lower, Akari Therapeutics and Alibaba Trade Actively

2 August 2022 в 00:36

ADRs End Lower, Akari Therapeutics and Alibaba Trade Actively

8 July 2022 в 02:15

ADRs End Higher; ABB, Akari Therapeutics Trade Actively

8 July 2022 в 02:15

ADRs End Higher; ABB, Akari Therapeutics Trade Actively

20 May 2022 в 01:35

ADRs End Higher; Akari Therapeutics, Natuzzi Trade Actively

20 May 2022 в 01:30

ADRs End Higher; Akari Therapeutics, Natuzzi Trade Actively

About company Akari Therapeutics

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.
Address:
75/76 Wimpole Street, London, United Kingdom, W1G 9RT
Company name: Akari Therapeutics
Issuer ticker: AKTX
ISIN: US00972G1085
Country: UK
Exchange: NASDAQ
Currency: $
IPO date: 2015-09-21
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.akaritx.com

On which stock exchange are Akari Therapeutics (AKTX) stocks traded?

Akari Therapeutics (AKTX) stocks are traded on NASDAQ.

What is the ticker of Akari Therapeutics stocks (AKTX)?

The stock ticker of Akari Therapeutics’s stocks or in other words, the code is AKTX. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Akari Therapeutics (AKTX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Akari Therapeutics (AKTX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Akari Therapeutics (AKTX) stocks traded?

Akari Therapeutics (AKTX) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Akari Therapeutics (AKTX) stocks today?

The current price of Akari Therapeutics stocks on 29.04.2024 is 1.185 dollars. per share.

What is the dynamics of Akari Therapeutics (AKTX) stocks from the beginning of the year?

Akari Therapeutics (AKTX) quotes have increased by -59.09% from the beginning of the year up to 1.185 dollars. per 1 stocks.

How much did Akari Therapeutics (AKTX) stocks increase in апреле 2024?

This month Akari Therapeutics (AKTX) quotes have increased by -21.52% to 1.185 dollars. per share.

How much are Akari Therapeutics (AKTX) stocks worth?

Today, on October, 29.04.2024 Akari Therapeutics’s (AKTX) stocks cost 1.185 dollars..

What is the market capitalization of Akari Therapeutics (AKTX)?

Capitalization is the market value of Akari Therapeutics (AKTX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Akari Therapeutics (AKTX) is estimated at about 11994951005 dollars.